Labcorp EBITDA Margin 2010-2024 | LH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Labcorp (LH) over the last 10 years. The current EBITDA margin for Labcorp as of March 31, 2024 is .
| Labcorp EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2023-12-31 |
$12.16B |
$1.30B |
10.71% |
| 2023-09-30 |
$12.04B |
$1.37B |
11.34% |
| 2023-06-30 |
$11.85B |
$1.48B |
12.49% |
| 2023-03-31 |
$11.74B |
$1.63B |
13.90% |
| 2022-12-31 |
$11.87B |
$1.97B |
16.64% |
| 2022-09-30 |
$10.76B |
$2.44B |
22.66% |
| 2022-06-30 |
$11.96B |
$2.88B |
24.12% |
| 2022-03-31 |
$12.88B |
$3.24B |
25.13% |
| 2021-12-31 |
$13.14B |
$3.63B |
27.60% |
| 2021-09-30 |
$16.56B |
$4.56B |
27.57% |
| 2021-06-30 |
$16.39B |
$5.27B |
32.16% |
| 2021-03-31 |
$15.32B |
$4.82B |
31.48% |
| 2020-12-31 |
$13.98B |
$3.53B |
25.27% |
| 2020-09-30 |
$12.44B |
$2.55B |
20.46% |
| 2020-06-30 |
$11.48B |
$1.37B |
11.94% |
| 2020-03-31 |
$11.59B |
$1.41B |
12.12% |
| 2019-12-31 |
$11.56B |
$1.91B |
16.50% |
| 2019-09-30 |
$11.39B |
$1.86B |
16.33% |
| 2019-06-30 |
$11.29B |
$1.85B |
16.40% |
| 2019-03-31 |
$11.28B |
$1.88B |
16.70% |
| 2018-12-31 |
$11.33B |
$1.88B |
16.56% |
| 2018-09-30 |
$11.29B |
$1.91B |
16.89% |
| 2018-06-30 |
$11.08B |
$1.89B |
17.07% |
| 2018-03-31 |
$10.74B |
$1.84B |
17.13% |
| 2017-12-31 |
$10.31B |
$1.84B |
17.83% |
| 2017-09-30 |
$9.90B |
$1.78B |
17.92% |
| 2017-06-30 |
$9.70B |
$1.76B |
18.16% |
| 2017-03-31 |
$9.60B |
$1.79B |
18.69% |
| 2016-12-31 |
$9.55B |
$1.77B |
18.53% |
| 2016-09-30 |
$9.52B |
$1.71B |
17.97% |
| 2016-06-30 |
$9.42B |
$1.69B |
17.98% |
| 2016-03-31 |
$9.26B |
$1.64B |
17.75% |
| 2015-12-31 |
$8.68B |
$1.46B |
16.77% |
| 2015-09-30 |
$7.89B |
$1.38B |
17.50% |
| 2015-06-30 |
$7.13B |
$1.25B |
17.57% |
| 2015-03-31 |
$6.37B |
$1.12B |
17.60% |
| 2014-12-31 |
$6.01B |
$1.15B |
19.15% |
| 2014-09-30 |
$5.94B |
$1.15B |
19.36% |
| 2014-06-30 |
$5.85B |
$1.15B |
19.71% |
| 2014-03-31 |
$5.80B |
$1.17B |
20.16% |
| 2013-12-31 |
$5.81B |
$1.22B |
21.06% |
| 2013-09-30 |
$5.78B |
$1.22B |
21.17% |
| 2013-06-30 |
$5.73B |
$1.22B |
21.33% |
| 2013-03-31 |
$5.69B |
$1.23B |
21.61% |
| 2012-12-31 |
$5.67B |
$1.26B |
22.15% |
| 2012-09-30 |
$5.63B |
$1.29B |
22.86% |
| 2012-06-30 |
$5.62B |
$1.28B |
22.82% |
| 2012-03-31 |
$5.60B |
$1.23B |
22.05% |
| 2011-12-31 |
$5.54B |
$1.18B |
21.36% |
| 2011-09-30 |
$5.47B |
$1.17B |
21.40% |
| 2011-06-30 |
$5.34B |
$1.16B |
21.71% |
| 2011-03-31 |
$5.18B |
$1.20B |
23.12% |
| 2010-12-31 |
$5.00B |
$1.19B |
23.74% |
| 2010-09-30 |
$4.87B |
$1.16B |
23.84% |
| 2010-06-30 |
$4.78B |
$1.16B |
24.28% |
| 2010-03-31 |
$4.73B |
$1.14B |
23.98% |
| 2009-12-31 |
$4.70B |
$1.14B |
24.28% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.686B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
